Shepherd A M, Stewart W K, Thjodleifsson B, Wormsley K G
Br Med J. 1974 Jan 19;1(5898):96-8. doi: 10.1136/bmj.1.5898.96.
The effect of medical treatment has been studied in four patients with end-stage renal failure who suffered from severe spontaneous gastric hypersecretion, associated with very low levels of intraduodenal pH in two cases. Atropine decreased the overnight gastric acid output, but the residual acid secretion and duodenal content of acid remained dangerously high in one of the patients. Secretin inhibited the basal gastric secretion of acid in all cases and converted the pH of the duodenal contents to alkaline. While atropine cannot be used to control the gastric hypersecretion, secretin may prove to be valuable in the therapeutic management of the gastric hypersecretion of patients with chronic renal failure.
对四名终末期肾衰竭患者进行了医学治疗效果的研究,这些患者患有严重的自发性胃酸分泌过多,其中两例十二指肠内pH值极低。阿托品降低了夜间胃酸分泌量,但其中一名患者的残余酸分泌和十二指肠酸含量仍处于危险的高水平。促胰液素在所有病例中均抑制了基础胃酸分泌,并使十二指肠内容物的pH值变为碱性。虽然阿托品不能用于控制胃酸分泌过多,但促胰液素可能在慢性肾衰竭患者胃酸分泌过多的治疗管理中被证明具有价值。